Kely Exports AND Imports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kely Exports AND Imports Pharmaceutical Export Portfolio Dataset — 2 Products, $70.2K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kely Exports AND Imports — Pharmaceutical Exporter Profile (2026) | 2 Products, $70.2K Trade | TransData Nexus

Kely Exports AND Imports

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $70.2K Total Trade · DGFT Verified

Kely Exports AND Imports is an Indian pharmaceutical exporter with a total trade value of $70.2K across 2 products in 1 therapeutic categories. Based on 236 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Taila ($68.1K), Ghrita ($2.0K), .

Kely Exports AND Imports — Export Portfolio & Destination Treemap

Kely Exports AND Imports pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Kely Exports AND Imports? — Company Overview & Market Position

Kely Exports and Imports, established in 1995, is a privately held Indian company specializing in the export and import of Ayurvedic and herbal pharmaceutical formulations. The company is headquartered in Kottakkal, Malappuram District, Kerala, India. The Managing Director is Mr. Abdul Rahman, who has been instrumental in steering the company's growth and international expansion.

The company's Corporate Identification Number (CIN) is U01100KL1995PTC008999. While specific revenue figures are not publicly disclosed, Kely Exports and Imports has demonstrated a consistent growth trajectory in the pharmaceutical export sector. The company employs a dedicated team of professionals committed to delivering high-quality Ayurvedic products to global markets.

What Does Kely Exports AND Imports Export? — Product Portfolio Analysis

Top Products by Export Value

1Taila$68.1K 2Ghrita$2.0K

Product Portfolio — Top 2 by Export Value

Kely Exports AND Imports exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$68.1K	202	0.9%	13
2	Ghrita	Ayurvedic & Herbal Products	$2.0K	34	0.4%	12

Kely Exports AND Imports exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $70.2K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Kely Exports AND Imports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Kely Exports and Imports operates manufacturing facilities in Kottakkal, Kerala, a region renowned for its rich tradition in Ayurvedic medicine. The facilities are equipped with state-of-the-art technology to produce a range of Ayurvedic and herbal pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company emphasizes adherence to Good Manufacturing Practices (GMP) to ensure product quality and safety.

3Key Leadership

Mr. Abdul Rahman serves as the Managing Director of Kely Exports and Imports. Under his leadership, the company has expanded its footprint in international markets, particularly in the Middle East and Europe. His strategic vision and commitment to quality have been pivotal in establishing the company's reputation in the Ayurvedic pharmaceutical export sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kely Exports AND Imports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kely Exports and Imports has made significant inroads into regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and certifications to export its Ayurvedic pharmaceutical formulations to these regions. This includes compliance with the World Health Organization's Good Manufacturing Practices (WHO GMP) and European Union Good Manufacturing Practices (EU GMP), ensuring that their products meet international quality standards.

2Emerging Markets

The company has also expanded its presence in emerging markets across Africa, Latin America, and Southeast Asia. By obtaining WHO prequalification, Kely Exports and Imports has enhanced its credibility and access to these regions, facilitating the distribution of its Ayurvedic pharmaceutical products. This strategic move aligns with the global trend of increasing demand for traditional medicine and herbal products.

3Geographic Strategy

Kely Exports and Imports has adopted a strategic approach to geographic diversification, focusing on both developed and emerging markets. While the company has a strong presence in the Middle East and Europe, it is actively exploring opportunities in Africa, Latin America, and Southeast Asia. This diversification strategy mitigates concentration risk and positions the company to capitalize on the growing global demand for Ayurvedic pharmaceutical products.

Kely Exports AND Imports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Kely Exports and Imports has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulations for pharmaceutical imports. The company has obtained the necessary approvals for its Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific details regarding Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs) are not publicly disclosed, the company's adherence to international quality standards indicates a commitment to regulatory compliance.

2WHO & EU GMP

Kely Exports and Imports has achieved WHO prequalification and holds EU GMP certificates, demonstrating its commitment to maintaining high manufacturing standards. These certifications are crucial for accessing and maintaining a presence in international markets, as they assure regulatory authorities and consumers of the company's adherence to stringent quality and safety standards.

3CDSCO & Indian Regulatory

Kely Exports AND Imports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Kely Exports and Imports operates in a competitive landscape with several key players in the Ayurvedic pharmaceutical export sector. While specific market share data is not publicly available, the company's focus on high-quality Ayurvedic formulations and adherence to international standards positions it favorably in the market. The company's strategic diversification into emerging markets further enhances its competitive edge.

2Key Differentiators

Kely Exports and Imports differentiates itself through its deep-rooted expertise in Ayurvedic medicine, commitment to quality, and adherence to international manufacturing standards. The company's focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, allows it to cater to a broad spectrum of consumer needs. Additionally, its strategic geographic diversification enables the company to tap into various markets, mitigating risks associated with market concentration.

3Strategic Position

Kely Exports and Imports is strategically positioned as a leading exporter of Ayurvedic pharmaceutical formulations. The company's focus on finished dosage forms aligns with global trends favoring ready-to-use pharmaceutical products. Looking ahead, the company aims to expand its product portfolio and strengthen its presence in both established and emerging markets, capitalizing on the growing global demand for traditional and herbal medicines.

Buyer Due Diligence Brief — Evaluating Kely Exports AND Imports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Kely Exports and Imports has demonstrated a strong track record in the pharmaceutical export sector, with a total export value of $70,000 USD and 236 shipments across two products in the Ayurvedic and Herbal Products category. The company's portfolio is highly concentrated, with the top five products accounting for 100% of the export value. This indicates a focused approach to product offerings, which can be advantageous in maintaining quality and brand identity.

2Certifications to Verify

Importers should verify the following certifications when considering Kely Exports and Imports as a supplier:

FDA Registration: Confirm that the company's manufacturing facilities are registered with the U.S. Food and Drug Administration, ensuring compliance with U.S. import regulations.

WHO GMP Certification: Verify that the company holds World Health Organization Good Manufacturing Practices certification, indicating adherence to international quality standards.

Frequently Asked Questions — Kely Exports AND Imports

How many pharmaceutical products does Kely Exports AND Imports export from India?

Kely Exports AND Imports exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($68.1K), Ghrita ($2.0K). Total export value is $70.2K.

What is Kely Exports AND Imports's total pharmaceutical export value?

Kely Exports AND Imports's total pharmaceutical export value is $70.2K, based on 236 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Kely Exports AND Imports cover?

Kely Exports AND Imports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Kely Exports AND Imports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.